OBJECTIVE: Prior research indicates PTSD is associated with cardiovascular and metabolic disease. A number of different treatments for PTSD can be effective in reducing PTSD symptoms. The aim of this study is to systematically review studies which determine whether treatment for PTSD is associated with better cardiovascular and metabolic outcomes. METHOD: Five different databases were searched in a systematic manner, and 11 relevant studies were recovered and analyzed. FINDINGS: Treatments associated with PTSD improvement and found to be effective in improving cardiovascular or metabolic outcomes among individuals with PTSD include cognitive behavioral therapy (heart rate variability and blood pressure), prolonged exposure (heart rate and heart rate variability) and SSRIs (blood pressure). CONCLUSIONS: Multiple PTSD treatment modalities were associated with improved cardiovascular health and reduced risk of cardiovascular-related mortality. Given the small sample sizes, lack of follow-up studies and the extensive use of military populations in studies on PTSD and chronic diseases, these results should be interpreted with caution. More studies are needed that assess and verify whether PTSD treatments mitigate the risk for metabolic, diabetic and cardiovascular disease.
OBJECTIVE: Prior research indicates PTSD is associated with cardiovascular and metabolic disease. A number of different treatments for PTSD can be effective in reducing PTSD symptoms. The aim of this study is to systematically review studies which determine whether treatment for PTSD is associated with better cardiovascular and metabolic outcomes. METHOD: Five different databases were searched in a systematic manner, and 11 relevant studies were recovered and analyzed. FINDINGS: Treatments associated with PTSD improvement and found to be effective in improving cardiovascular or metabolic outcomes among individuals with PTSD include cognitive behavioral therapy (heart rate variability and blood pressure), prolonged exposure (heart rate and heart rate variability) and SSRIs (blood pressure). CONCLUSIONS: Multiple PTSD treatment modalities were associated with improved cardiovascular health and reduced risk of cardiovascular-related mortality. Given the small sample sizes, lack of follow-up studies and the extensive use of military populations in studies on PTSD and chronic diseases, these results should be interpreted with caution. More studies are needed that assess and verify whether PTSD treatments mitigate the risk for metabolic, diabetic and cardiovascular disease.
Authors: Greg M Reger; Patricia Koenen-Woods; Kimberlee Zetocha; Derek J Smolenski; Kevin M Holloway; Barbara O Rothbaum; JoAnn Difede; Albert A Rizzo; Amanda Edwards-Stewart; Nancy A Skopp; Matthew Mishkind; Mark A Reger; Gregory A Gahm Journal: J Consult Clin Psychol Date: 2016-09-08
Authors: Jeffrey F Scherrer; Joanne Salas; F David Schneider; Matthew J Friedman; Carissa van den Berk-Clark; Kathleen M Chard; Sonya B Norman; Patrick J Lustman; Peter Tuerk; Paula P Schnurr; Beth E Cohen Journal: J Psychosom Res Date: 2020-05-04 Impact factor: 3.006
Authors: Lisa S Talbot; Madhu N Rao; Beth E Cohen; Anne Richards; Sabra S Inslicht; Aoife OʼDonovan; Shira Maguen; Thomas J Metzler; Thomas C Neylan Journal: Psychosom Med Date: 2015-05 Impact factor: 4.312
Authors: Jeffrey F Scherrer; Joanne Salas; Matthew J Friedman; Beth E Cohen; F David Schneider; Patrick J Lustman; Carissa van den Berk-Clark; Kathleen M Chard; Peter Tuerk; Sonya B Norman; Paula P Schnurr Journal: Health Psychol Date: 2020-03-30 Impact factor: 4.267
Authors: Kyle J Bourassa; Elizabeth S Stevens; Andrea C Katz; Barbara O Rothbaum; Greg M Reger; Aaron M Norr Journal: Psychosom Med Date: 2020-01 Impact factor: 4.312
Authors: Juliana Zambrano; Christopher M Celano; James L Januzzi; Christina N Massey; Wei-Jean Chung; Rachel A Millstein; Jeff C Huffman Journal: J Am Heart Assoc Date: 2020-11-07 Impact factor: 5.501